Moreover, Hb‐adjusted dosing could prevent unnecessary transfusions, hereby reducing the risk of infections, immunizations, wrong‐patient blood transfusion errors and transfusion‐associated circulatory overload,[52] where specifically the latter comes in risk groups at a frequency of up to 1:12.[3]. The gene discussed is GSTM1; the disease is infection.